pubmed-article:15515120 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:15515120 | lifeskim:mentions | umls-concept:C0330390 | lld:lifeskim |
pubmed-article:15515120 | lifeskim:mentions | umls-concept:C0011306 | lld:lifeskim |
pubmed-article:15515120 | lifeskim:mentions | umls-concept:C0035696 | lld:lifeskim |
pubmed-article:15515120 | lifeskim:mentions | umls-concept:C0162807 | lld:lifeskim |
pubmed-article:15515120 | lifeskim:mentions | umls-concept:C0021743 | lld:lifeskim |
pubmed-article:15515120 | lifeskim:mentions | umls-concept:C1610033 | lld:lifeskim |
pubmed-article:15515120 | lifeskim:mentions | umls-concept:C1254042 | lld:lifeskim |
pubmed-article:15515120 | lifeskim:mentions | umls-concept:C0033268 | lld:lifeskim |
pubmed-article:15515120 | lifeskim:mentions | umls-concept:C0205263 | lld:lifeskim |
pubmed-article:15515120 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:15515120 | pubmed:dateCreated | 2005-4-11 | lld:pubmed |
pubmed-article:15515120 | pubmed:abstractText | The development of dendritic cell (DC)-based vaccines using antigen-encoding mRNA requires identification of the critical parameters for efficient ex vivo loading of DCs. Exogenously delivered mRNA can induce DC activation, but the molecular mechanisms involved are unknown. The aim of the present study was to identify the means by which mRNA-dependent activation of DCs occurs. | lld:pubmed |
pubmed-article:15515120 | pubmed:language | eng | lld:pubmed |
pubmed-article:15515120 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15515120 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:15515120 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15515120 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15515120 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15515120 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:15515120 | pubmed:month | Apr | lld:pubmed |
pubmed-article:15515120 | pubmed:issn | 1099-498X | lld:pubmed |
pubmed-article:15515120 | pubmed:author | pubmed-author:GerberHH | lld:pubmed |
pubmed-article:15515120 | pubmed:author | pubmed-author:McCulloughK... | lld:pubmed |
pubmed-article:15515120 | pubmed:author | pubmed-author:SummerfieldAA | lld:pubmed |
pubmed-article:15515120 | pubmed:author | pubmed-author:CeppiMM | lld:pubmed |
pubmed-article:15515120 | pubmed:author | pubmed-author:RuggliNN | lld:pubmed |
pubmed-article:15515120 | pubmed:author | pubmed-author:TacheVV | lld:pubmed |
pubmed-article:15515120 | pubmed:copyrightInfo | Copyright (c) 2004 John Wiley & Sons, Ltd. | lld:pubmed |
pubmed-article:15515120 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:15515120 | pubmed:volume | 7 | lld:pubmed |
pubmed-article:15515120 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:15515120 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:15515120 | pubmed:pagination | 452-65 | lld:pubmed |
pubmed-article:15515120 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:15515120 | pubmed:meshHeading | pubmed-meshheading:15515120... | lld:pubmed |
pubmed-article:15515120 | pubmed:meshHeading | pubmed-meshheading:15515120... | lld:pubmed |
pubmed-article:15515120 | pubmed:meshHeading | pubmed-meshheading:15515120... | lld:pubmed |
pubmed-article:15515120 | pubmed:meshHeading | pubmed-meshheading:15515120... | lld:pubmed |
pubmed-article:15515120 | pubmed:meshHeading | pubmed-meshheading:15515120... | lld:pubmed |
pubmed-article:15515120 | pubmed:meshHeading | pubmed-meshheading:15515120... | lld:pubmed |
pubmed-article:15515120 | pubmed:meshHeading | pubmed-meshheading:15515120... | lld:pubmed |
pubmed-article:15515120 | pubmed:meshHeading | pubmed-meshheading:15515120... | lld:pubmed |
pubmed-article:15515120 | pubmed:meshHeading | pubmed-meshheading:15515120... | lld:pubmed |
pubmed-article:15515120 | pubmed:meshHeading | pubmed-meshheading:15515120... | lld:pubmed |
pubmed-article:15515120 | pubmed:year | 2005 | lld:pubmed |
pubmed-article:15515120 | pubmed:articleTitle | Double-stranded secondary structures on mRNA induce type I interferon (IFN alpha/beta) production and maturation of mRNA-transfected monocyte-derived dendritic cells. | lld:pubmed |
pubmed-article:15515120 | pubmed:affiliation | Institute of Virology and Immunoprophylaxis (IVI), Mittelhäusern, Switzerland. | lld:pubmed |
pubmed-article:15515120 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:15515120 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15515120 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15515120 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15515120 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15515120 | lld:pubmed |